Yes it’s a big pie controlled by two companies , edwards revenue is 80% of what AVR is in , so gives u a idea when revenue flows into a biotech what it means to the company value , so ask yourself what is the revenue potential for AVR , I believe the market size will be bigger with duraVR , why can’t it be given to 65 year olds ? This what makes this attractive , anyway let’s wait for trials next year or so , more positive data means only one thing , higher takeover price
Keep in mind both Medtronic and Edward bought into this market by taking over companies same status as AVR for billion plus dollars , anyone wish to confirm here.
U would think $3b plus is achievable if these results are replicated in the fda and ec trials ,why wouldn’t they? Just had 13 people (and some very sick) show results which mimics a potential cure.
- Forums
- ASX - By Stock
- Ann: Update on First In Human DurAVR THV Study
Yes it’s a big pie controlled by two companies , edwards revenue...
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M |
Open | High | Low | Value | Volume |
$17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 191 | $17.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.50 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 191 | 17.150 |
1 | 1460 | 17.000 |
1 | 196 | 16.950 |
1 | 682 | 16.910 |
1 | 42 | 16.900 |
Price($) | Vol. | No. |
---|---|---|
17.500 | 500 | 1 |
17.800 | 200 | 1 |
18.240 | 500 | 1 |
18.300 | 150 | 1 |
18.690 | 550 | 1 |
Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |